These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7343140)

  • 21. A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains.
    Kaslow DC; Quakyi IA; Syin C; Raum MG; Keister DB; Coligan JE; McCutchan TF; Miller LH
    Nature; 1988 May; 333(6168):74-6. PubMed ID: 3283563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Waiting for the vaccine: sporozoite vaccine research entails important progress in malaria epidemiology.
    Esposito F; Gambella R; Modiano D; Lamizana L; Lombardi S; Rotigliano G; Habluetzel A
    Parassitologia; 1991 Apr; 33(1):85-91. PubMed ID: 1841198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccination against malaria with live parasites.
    Rénia L; Grüner AC; Mauduit M; Snounou G
    Expert Rev Vaccines; 2006 Aug; 5(4):473-81. PubMed ID: 16989628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Progress of research on DNA vaccines against parasitosis].
    Qi WJ; Fang Q
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Jun; 23(3):340-4. PubMed ID: 22164511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The biotechnology-value chain: development of Sm14 as a schistosomiasis vaccine.
    Tendler M; Simpson AJ
    Acta Trop; 2008; 108(2-3):263-6. PubMed ID: 18834847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antiparasitic vaccines: where are we now?].
    Rogier C; Moukoko CE; Orlandi-Pradines E; Briolant S
    Rev Prat; 2007 Jan; 57(2):183-8. PubMed ID: 17432523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A perspective on malaria vaccines.
    Desowitz RS; Miller LH
    Bull World Health Organ; 1980; 58(6):897-908. PubMed ID: 6783333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative efficacy of pre-erythrocytic whole organism vaccine strategies against the malaria parasite.
    Friesen J; Matuschewski K
    Vaccine; 2011 Sep; 29(40):7002-8. PubMed ID: 21787828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Schistosomiasis vaccine development--the current picture.
    Waine GJ; McManus DP
    Bioessays; 1997 May; 19(5):435-43. PubMed ID: 9174407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospects for the development of malaria vaccines.
    Wernsdorfer WH
    Bull World Health Organ; 1981; 59(3):335-41. PubMed ID: 6976843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preerythrocytic malaria vaccine development.
    Mikolajczak SA; Aly AS; Kappe SH
    Curr Opin Infect Dis; 2007 Oct; 20(5):461-6. PubMed ID: 17762778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prospects of vaccination against schistosomiasis].
    Capron A
    Bull Acad Natl Med; 1989 Apr; 173(4):495-502; discussion 502-4. PubMed ID: 2790533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New approaches in vaccine development.
    Leclerc C
    Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):329-41. PubMed ID: 12818620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of vaccines against human parasitic diseases: tools, current status and perspectives.
    Abath FG
    Expert Opin Investig Drugs; 2000 Feb; 9(2):301-10. PubMed ID: 11060678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The species specificity of immunity generated by live whole organism immunisation with erythrocytic and pre-erythrocytic stages of rodent malaria parasites and implications for vaccine development.
    Inoue M; Tang J; Miyakoda M; Kaneko O; Yui K; Culleton R
    Int J Parasitol; 2012 Aug; 42(9):859-70. PubMed ID: 22846785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiation-attenuated schistosome vaccination--a brief historical perspective.
    Bickle QD
    Parasitology; 2009 Oct; 136(12):1621-32. PubMed ID: 19327194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The real difficulties for malaria sporozoite vaccine development: nonresponsiveness and antigenic variation.
    Good MF; Kumar S; Miller LH
    Immunol Today; 1988 Nov; 9(11):351-5. PubMed ID: 3076406
    [No Abstract]   [Full Text] [Related]  

  • 38. Interactions between malaria parasites and the host immune system.
    Engwerda CR; Good MF
    Curr Opin Immunol; 2005 Aug; 17(4):381-7. PubMed ID: 15950450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Schistosomiasis and malaria: another piece of the crossreactivity puzzle.
    Helmby H
    Trends Parasitol; 2007 Mar; 23(3):88-90. PubMed ID: 17229591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Achievements and perspectives of research into development of a vaccine against malaria].
    Wiśniewski M; Zak DJ
    Wiad Parazytol; 2010; 56(2):133-40. PubMed ID: 20707297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.